Temperature screening at airports and during passenger boarding has become one of the most visible public health interventions of the 21st century. Using infrared thermography or handheld devices, authorities rapidly assess travelers for elevated body temperature — a potential sign of infectious disease. While the practice predates the COVID-19 pandemic, it was adopted on a global scale from early 2020, forming a frontline defence against the importation and exportation of SARS-CoV-2. The logic is straightforward: identify febrile individuals, divert them for further assessment, and reduce the probability that an infected person will board an aircraft or cross a border. In practice, however, temperature screening sits at the centre of a complex and sometimes contentious debate about its actual effectiveness, opportunity cost, and role within layered biosecurity systems.

How Temperature Screening Works

Modern temperature screening relies primarily on two technologies: non-contact infrared thermometers (NCITs) and thermal imaging cameras. Handheld NCITs measure the infrared radiation emitted by the skin, typically from the forehead or wrist, and convert this into a temperature reading within seconds. Thermal cameras, often mounted on tripods or integrated into walk-through portals, capture a two-dimensional map of facial temperatures, flagging individuals whose readings exceed a predefined threshold. Mass screening at airports usually employs thermal cameras because they allow continuous, real-time monitoring of large passenger flows without requiring travellers to pause or interact directly with an operator.

Screening protocols vary by jurisdiction, but most follow a similar sequence. Travellers pass through an imaging zone where their maximum facial temperature is recorded. The system alerts staff if a reading crosses a threshold — commonly 38.0°C (100.4°F), though some settings use lower thresholds such as 37.5°C to increase sensitivity. Flagged individuals undergo a secondary assessment, often with a clinical-grade NCIT or oral thermometer, and complete a health questionnaire. If fever is confirmed, they may be denied boarding, referred to on-site medical personnel, or subject to additional testing. The entire process is designed to be non-invasive, rapid, and scalable, making it attractive for high-volume transit hubs.

The Historical Context: From SARS to COVID-19

Temperature screening at borders is not a new invention. During the 2003 SARS outbreak, countries including China, Canada, and Singapore deployed thermal scanners at airports to detect passengers with fever, a hallmark symptom of the disease. The 2009 H1N1 pandemic and the 2014 Ebola epidemic in West Africa prompted further use of entry and exit screening, often in combination with travel restrictions. These experiences created a playbook that public health authorities turned to in January 2020, when the novel coronavirus began spreading internationally from Wuhan, China. Within weeks, hundreds of airports had installed thermal cameras, and temperature checks became a standard part of pre-boarding and arrival procedures worldwide.

The rapid deployment was driven not only by the perceived utility of fever detection but also by a need to restore public confidence in air travel. Airlines and governments faced intense pressure to “do something” visible to reassure passengers and demonstrate that flying was safe. Temperature screening became a symbol of control — a simple, technology-based measure that could communicate vigilance to the travelling public. Yet the science behind its effectiveness was already being questioned by epidemiologists who had studied similar interventions in past outbreaks.

What the Scientific Evidence Shows

Multiple studies, including systematic reviews and modelling exercises, have assessed the effectiveness of traveller temperature screening for respiratory infections. A landmark analysis by Quilty and colleagues published in Eurosurveillance in early 2020 estimated that airport screening would miss between 42% and 46% of infected travellers during the COVID-19 incubation period, largely because many infected individuals are asymptomatic or pre-symptomatic at the time of travel. Another study in eLife used simulated data to conclude that even symptom-based screening (including temperature checks) could catch at most about half of incoming infectious travellers, and that relying on fever detection alone would have minimal impact on delaying or reducing epidemic spread.

The problem is biological as much as technological. Fever is not a universal early symptom. In COVID-19, fever may appear several days after viral shedding begins, meaning an individual can be highly infectious while registering a normal temperature. Children and older adults may not mount robust febrile responses, and a proportion of infections — particularly with Omicron variants — produce mild or no fever at all. Moreover, the use of antipyretic medications like acetaminophen or ibuprofen can temporarily suppress fever, allowing a sick traveller to pass screening undetected, whether unintentionally or deliberately.

False positives also erode the utility of screening. Environmental conditions (direct sunlight, drafts, air conditioning), recent physical exertion, consumption of hot beverages, and even emotional stress can raise facial skin temperature independent of core body temperature. The resulting false alarms create logjams at secondary screening stations, waste staff resources, and inconvenience healthy travellers. In some outbreak scenarios, the positive predictive value of a single temperature checkpoint can be extremely low, meaning the majority of those flagged are not actually infected.

Limitations and Operational Challenges

  • Asymptomatic and pre-symptomatic transmission: A significant fraction of COVID-19 transmission occurs from individuals without measurable fever. Screening only for elevated temperature leaves a large surveillance gap.
  • Incubation period variability: The time between exposure and symptom onset varies by pathogen. For many respiratory viruses, travellers departing an affected area may be in the incubation phase and show no signs, only to develop fever after arrival.
  • Environmental sensitivity: Thermal cameras and NCITs measure skin temperature, which fluctuates with ambient temperature, humidity, and airflow. Calibrating equipment for outdoor or semi-outdoor environments is challenging and can lead to systematic biases.
  • Human factors: Operator fatigue, inconsistent secondary assessment protocols, language barriers, and the pressure to keep passengers moving can cause inconsistent enforcement. In some settings, passengers are incentivised to hide symptoms for fear of quarantine or denied boarding, a phenomenon documented during Ebola and COVID-19 outbreaks.
  • Equipment limitations: The accuracy of mass thermal imaging systems is often lower than clinical thermometers. A U.S. Food and Drug Administration (FDA) guidance notes that thermal imaging systems must be used correctly, in controlled environments, and that their performance can be affected by factors such as the person's recent activity level and the presence of face coverings.

Temperature Screening as Part of a Multi-Layered Strategy

Public health agencies, including the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), have consistently emphasised that temperature screening should never be used in isolation. Instead, it is a single component of a comprehensive risk-mitigation framework that may include health declarations, pre-departure testing, vaccination requirements, mask mandates, improved ventilation, and post-arrival monitoring. During the COVID-19 pandemic, many countries combined entry screening with mandatory PCR or rapid antigen testing within 72 hours of departure, and later with proof of vaccination, which dramatically reduced the probability an infectious person would board a flight.

Layered strategies compensate for the weaknesses of individual interventions. For example, a traveller who is pre-symptomatic might slip past a temperature scanner but be caught by a rapid antigen test taken shortly before check-in. Another traveller who is fully vaccinated and boosted might have a mild breakthrough infection without fever but poses a lower transmission risk overall. When these layers function together, the overall system resilience improves, even if no single layer is perfect. Singapore’s Changi Airport and Israel’s Ben Gurion Airport, for example, deployed extensive multi-modal screening early in the pandemic, including temperature checks, PCR testing stations, and health questionnaires, alongside rigorous contact tracing for any detected case.

Psychological Impact: Reassurance or False Security?

One often-cited benefit of airport temperature screening is its effect on traveller confidence and staff morale. The visual presence of thermal cameras and health checkpoints can reassure the public that authorities are proactively managing risk, which may encourage a return to air travel during an outbreak. Surveys conducted during the COVID-19 pandemic indicated that passengers perceived temperature screening as an important safety measure, even when they were aware of its limitations. For airlines and airports, the perception of safety can be as economically significant as actual risk reduction.

However, this perceived security carries a potential downside. If travellers believe that a single temperature check is sufficient to guarantee a flight is “safe,” they may become less vigilant about other protective behaviours, such as mask-wearing, hand hygiene, or self-monitoring for symptoms after arrival. Experts have referred to this as the “false sense of security” problem — a behavioural hazard that can undermine the effectiveness of broader public health messaging. Communicating clearly about what temperature screening can and cannot do is therefore essential, yet it remains a communication challenge for airport operators and health authorities.

Alternatives and Complementary Technologies

The limitations of temperature screening have spurred interest in alternative and complementary technologies for infectious disease surveillance at points of entry. These include:

  • Digital health passes and vaccine certificates: Apps that verify vaccination or test status prior to travel have become mainstream, integrating with airline check-in systems to reduce manual document checks.
  • Wastewater surveillance: Testing aircraft lavatory waste or airport terminal wastewater can detect the presence of SARS-CoV-2 or other pathogens in aggregated populations, providing an early warning signal without individual screening.
  • Symptom and exposure questionnaires: Digital health declarations, sometimes integrated with QR-code based entry systems, collect data on recent symptoms, contacts, and travel history. While reliant on truthful self-reporting, they add an additional layer of risk stratification.
  • On-site rapid testing: Some airports have built dedicated testing facilities capable of processing hundreds of rapid molecular or antigen tests per hour. Positive individuals can be isolated immediately, offering higher sensitivity and specificity than temperature screening alone.
  • Machine vision and vital-sign monitoring: Prototype systems are exploring the use of video-based heart rate, respiratory rate, and even cough detection, though these remain experimental and raise privacy concerns.

Evolving Standards and Guidance

International guidance on traveller screening continues to evolve. The WHO’s interim guidance on mass screening at points of entry (updated during the pandemic) advises that temperature screening can be implemented as part of a broader risk-assessment strategy but caution against relying on it as a single measure. The International Civil Aviation Organization (ICAO) and the International Air Transport Association (IATA) have similarly published layered biosecurity frameworks that place temperature screening within a hierarchy of controls, alongside administrative, engineering, and personal protective measures. These frameworks recognise that no single intervention can eliminate the risk of transmission in air travel, and that effectiveness should be measured at the system level, not by the performance of a solitary checkpoint.

The Future of Infectious Disease Screening at Airports

As the world transitions to managing COVID-19 as an endemic disease, many of the temporary screening infrastructure installed during the pandemic is being dismantled. Some airports have removed thermal cameras entirely, while others are integrating them into broader health-security systems that can be reactivated for future outbreaks. The post-pandemic era is likely to see a more nuanced deployment of temperature screening: as a rapid-alert mechanism during the early phase of an emerging pathogen, rather than a routine tool. Advances in sensor technology and artificial intelligence may improve the accuracy and throughput of non-contact temperature measurement, but the fundamental biological limitation — that many infections are not immediately febrile — will remain.

Future designs may also embed screening within smarter, less intrusive passenger journeys. For instance, thermal sensors could be integrated into existing security or check-in infrastructure, collecting data passively without creating dedicated chokepoints. Combined with wastewater monitoring and digital health credential verification, this could create a ‘sanitary corridor’ where multiple data streams collectively assess risk without reliance on a single measurement. Such an approach would require robust privacy safeguards, global standardisation, and public trust, but it offers a glimpse of how health screening might evolve in an interconnected world.

Conclusion

Temperature screening at airports and during boarding processes is a well-intentioned and visible public health measure that has a place in the global defence against infectious disease outbreaks. It can identify some febrile travellers quickly and non-invasively, potentially averting a small number of transmissions. However, the scientific evidence is clear: alone, it is insufficient to stop the international spread of respiratory pathogens like SARS-CoV-2, influenza, or future emerging viruses. The technique is limited by the natural history of infection, environmental variables, and human behaviour. Its greatest value emerges when integrated into a layered, multi-modal strategy that includes testing, vaccination, health declarations, ventilation, and rapid public health response. Communicating the true capabilities and limits of temperature screening is essential to maintain appropriate vigilance among travellers and staff. As the aviation industry and health authorities look ahead to the next pandemic threat, the challenge will be to retain the lessons learned — keeping the tools that work, discarding those that do not, and investing in a smarter, more adaptive screening architecture that prioritises both health security and the seamless movement of people.